TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in TScan Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −1 vs. Q1 2022
- Shares held
- 9.68M
- +274.4K (+2.9%) vs. Q1 2022
- Total value
- $30.4M
- +$4.11M (+15.6%) vs. Q1 2022
- New holders
- 6
- 7 more added
- Sold out
- 7
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 2,784,792 | $8.76M | 0.05% | +1,359,792+95.4% | Added |
| BlackRock Inc. | 1,514,964 | $4.76M | 0.00% | −4,224−0.3% | Reduced |
| Deer Management Co. LLC | 1,245,505 | $3.92M | 0.25% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $3.39M | 0.18% | 00.0% | Unchanged |
| Tang Capital Management LLC | 747,800 | $2.35M | 0.36% | +547,800+273.9% | Added |
| DC Funds, LP | 630,000 | $1.98M | 27.33% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 550,000 | $1.73M | 0.00% | 00.0% | Unchanged |
| Newtyn Management, LLC | 248,611 | $782.0K | 0.15% | +248,611 | New |
| Vanguard Group Inc | 226,064 | $711.0K | 0.00% | −865−0.4% | Reduced |
| Tekla Capital Management LLC | 200,000 | $629.0K | 0.02% | 00.0% | Unchanged |
| Woodline Partners LP | 132,317 | $416.0K | 0.01% | −4,613−3.4% | Reduced |
| Bridgeway Capital Management, LLC | 115,000 | $362.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 57,089 | $180.0K | 0.00% | +18,013+46.1% | Added |
| DC Investments Management, LLC | 35,563 | $112.0K | 0.25% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 34,101 | $107.0K | 0.00% | +942+2.8% | Added |
| Marquette Asset Management, LLC | 28,895 | $91.0K | 0.03% | 00.0% | Unchanged |
| LPL Financial LLC | 16,000 | $50.0K | 0.00% | +16,000 | New |
| State Street Corp | 13,400 | $42.0K | 0.00% | +800+6.3% | Added |
| Jane Street Group, LLC | 10,176 | $32.0K | 0.00% | +10,176 | New |
| Tower Research Capital LLC (TRC) | 9,027 | $28.0K | 0.00% | +1,138+14.4% | Added |
| Cannell Capital LLC | 3,654 | $11.0K | 0.00% | +3,654 | New |
| UBS Group AG | 1,148 | $4.00K | 0.00% | +1,148 | New |
| Atlas Capital Advisors LLC | 896 | $2.82K | 0.00% | +896 | New |
| Wells Fargo & Company | 46 | $0 | 0.00% | +5+12.2% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,021,764−100.0% | Sold out |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −669,513−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −158,944−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −361−100.0% | Sold out |